|
Chris Mirabelli joined HealthCare Ventures as a Managing Director in 2000. Dr. Mirabelli was chairman of the board and chief executive officer of LeukoSite, Inc. from 1993 through 1999, a company in which HealthCare Ventures was the lead investor. Dr. Mirabelli was a co-founder of Isis Pharmaceuticals and served with SmithKline and French Laboratories R&D Division.
Dr. Mirabelli received his doctorate in molecular pharmacology from Baylor College of Medicine. | 